Monday, May 13, 2013

Spring Hepatitis Newsletters- Waiting for Approval of Drugs... What About Herbal Supplements?

Hepatitis C Newsletters

United States

Hepatitis Foundation International (HFI)
The Hepatitis Foundation International is dedicated to liver health and the prevention of liver related diseases. We inform and educate by making available reliable and up-to-date facts. We want you to make well-informed decisions for yourself and your loved ones' health and well-being. We are proud to present this website as your personal Internet gateway to hepatitis information and liver care.

The May-June 2013 Newsletter

MAY is Hepatitis Awareness Month 
Billy’s Story by Kathy Gacos Sister

HFI Offers Free Health Savings Card

Some Teens Lose Protection Despite HBV Vaccination as Infants

EU Approves Pegasys in Children Aged Five Years and Older

One Drink a Day is NOT OK

Thousands Exposed to HIV and HCV in Dentist’s Office

Waiting for Approval of Drugs... What About Herbal Supplements?
Why does it take so long for drugs to be approved by the Food and Drug
Administration (FDA)?
The FDA serves as a guardian of your liver. Every drug on the market is made up of chemicals that must be processed through your liver. Careful year long studies of these combinations must be approved first in tests on animals and then humans to observe any side effects that might damage the liver or other organs in the body.
However; herbal and dietary supplements are not under such regulation. Like all drugs or things ingested, herb and dietary supplements also have to be processed through your liver and can cause toxic reactions and serious liver damage.
Who’s in the Race for HCV Treatment?

Organ Donation Glitch

New York Presbyterian Hospital - Liver Connection Patient Newsletter
This quarterly newsletter contains articles addressing all aspects of life before and after liver transplantation

In The Spring Issue

Silvia's Corner — Silvia Hafliger, MD
Reflections on a Successful Transplant Journey
As the liver center is celebrating 15 years, and we have honored patients who have lived up to 25 years with their new liver, I would like to share with you some reflections that might help you on your own journey. Foremost, remember, transplant is a treatment; it is never a cure. Receiving a new liver is just one step to get you back to a better quality of life.

Nutrition is a critical part of success in the pre and post transplant patient. During the evaluation, you will have a nutrition screen and may be referred to meet with one of our transplant nutritionists. Too much salt, fluid or muscle wasting can be very harmful for patients before transplant while poor dietary choices can affect your success post-transplant!
Patients with liver disease have to make changes in their diet in order to adjust for decreased liver functioning and to maintain their overall health.

The Pharmacy Corner — Over The Counter Medications to Avoid After Transplant: NSAIDs
If you have pain, headache, or fever, the only medication you should take is acetaminophen or Tylenol®. Most transplant recipients can take 4,000 mg of acetaminophen per day, but liver transplant recipients should only take 2,000 mg per day (eg. 4 extra strength Tylenol® tablets per day).

Transplant Support Groups

Transplant Resources

HCV Advocate Newsletter
The HCV Advocate newsletter is a valuable resource designed to provide the hepatitis C community with monthly updates on events, clinical research, and education

In This Issue:
The Next Wave: Janssen/Tibotec and Gilead File for FDA Approval
Alan Franciscus, Editor-in-Chief

HEALTHWISE: Mother's Day in the Shadow of Hepatitis C
Lucinda K. Porter, RN

Lucinda K. Porter, RN

DISABILITY & BENEFITS: Why Is Social Security Disability So Difficult to Get?
Jacques Chambers, CLU

GI & Hepatology News
GI & Hepatology News is the official newspaper of the AGA Institute and provides the gastroenterologist with timely and relevant news and commentary about clinical developments and about the impact of health-care policy. The newspaper is led by an internationally renowned board of editors.

View Current Issue (VOL. 7 NO. 5 MAY 2013): PDF Or Interactive Version

Inside The May Issue

Small study finds miravirsen effective in HCV

Postmenopausal status doubles hepatic steatosis risk

Norovirus: Tops in kids’ acute gastroenteritis

HepChat is our monthly electronic newsletter sharing news and information about hepatitis and the projects and activities Hepatitis Victoria is working on.

May 2013 Edition

The Hepatitis C Treatment Outcome Study
Project Summary:
You are invited to take part in a study designed to determine some of the physical, psychological, and social factors associated with Hepatitis C treatment outcomes. Previous research has indicated that certain physical and psychological profiles predict better treatment outcomes across a range of medical conditions. However, little is known of how these factors predict treatment outcomes in Hepatitis C. The primary objective of this research is to increase understanding of individual profiles that are associated with better Hepatitis C treatment outcomes
Continue Reading..

HepCBC monthly newsletter
The Canadian newsletter contains the latest research results, government policy changes, activities and campaigns you can get involved in, articles by patients and caregivers, and a list of support groups plus other useful links.

In The May Issue

World Hepatitis Day


No comments:

Post a Comment